Specialty pharmaceutical company Warner Chilcott plc (WCRX) Friday said the United States Food and Drug Administration or FDA has approved a 200 mg strength of tetracycline-class oral antibiotic DORYX Delayed-Release Tablets.
The company said it anticipates the commercially launch of DORYX Delayed-Release 200 mg Tablets in July.
For comments and feedback: editorial@rttnews.com